Medical/Pharmaceuticals

Dontia Alliance introduced its first Advanced Implant Strategies Centre of Excellence in Malaysia and four (4) other centres are in the pipeline

* The first AIS Centre was launched in Penang, Malaysia on 8 June 2024 *  Four (4) more AIS Centres are slated to be launched in Singapore, Hong Kong (SAR), Vietnam and the Philippines in the next two years SINGAPORE, June 10, 2024 /PRNewswire/ -- Dontia Alliance Pte. Ltd. ("DA") introduced its...

2024-06-10 10:00 2798

ILJIN SNT Co., Ltd. Announces Its Intention to Vote Against Aurinia Pharmaceuticals's Revised Equity Incentive Plan Proposal

SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Dear Fellow Shareholders, ILJIN SNT Co., Ltd. ("ILJIN") is a long-standing investor of Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company"), and, together with its affiliates, currently holds more than 5% of Aurinia's common stock. As one of...

2024-06-07 23:49 5702

deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans

A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate and nature of mutations in mitochondrial DNA (mtDNA) and the peculiar dynamics of its maternal transmission REYKJAVIK, Iceland, June 7, 2024 /PRNewswire/ -- In a paper published toda...

2024-06-07 23:00 2740

THRIVING BEYOND CANCER: Pantai Hospital Kuala Lumpur's Heartfelt Month of Celebration and Support to Cancer Survivors with Special June Activities

KUALA LUMPUR, Malaysia, June 7, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL), a beacon of medical excellence and compassionate patient care, proudly announces a series of events in celebration ofCancer Survivor Month. These activities underscore PHKL's unwavering commitment to support...

2024-06-07 20:50 4617

IONETIX Produces First Batch of Actinium-225

LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of Actinium-225 ("Ac-225") at its isotope manufacturing facility located inLansing, Michigan. This fir...

2024-06-07 20:27 1835

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024

New translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection BRII-179 as add-on therapy induces functional antibody responses and contributes toimproved sustained HBsAg loss in PEG-IFNa-t...

2024-06-07 19:00 2427

Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma

SINGAPORE, June 7, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced that clinical data from its first-in-class autologous hepatitis B virus (HBV)-specific...

2024-06-07 16:51 2443

3 Major Product Releases at 3Shape Discover Event

* TRIOS Core - New TRIOS intraoral scanner system for just $12,400 * Remodeled TRIOS 3 intraoral scanner - the classic gets new look * TRIOS Ready Tips - single-use intraoral scanner tips for TRIOS 5 COPENHAGEN, Denmark, June 7, 2024 /PRNewswire/ -- 3Shape announces the launch of three excit...

2024-06-07 15:39 576

MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease

TAINAN, June 7, 2024 /PRNewswire/ -- MLB (Merry Life Biomedical Company, Ltd., Taiwan: https://www.tmlbio.com/ ), a biomedical company, announced that the U.S. Food and Drug Administration (FDA) has approved IND application forTML-6, an novel drug to treat Alzheimer's dis...

2024-06-07 15:00 2127

Potential Add-on Treatment for Patients with Parkinson's Disease: Stimvia Completes Pilot Study and Announces Promising Initial Results

PRAGUE, June 7, 2024 /PRNewswire/ -- Stimvia , a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson's Disease (PD) and is expecting promising results.   ...

2024-06-07 07:00 2561

NDA for Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Treating Alzheimer's Dementia

TOKYO, June 6, 2024 /PRNewswire/ -- Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) inJapan for the Rivastigmine Twice Weekly Transdermal Patch for treating mild to modera...

2024-06-06 17:33 2538

Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products

SUZHOU, China, June 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of the Company, entered into a research and collaboration agreement (the "Collaboration Agreement") with ArriVen...

2024-06-06 10:21 2114

RemeGen Showcases Research Results at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, Highlighting Its Prolific Innovation in Global Cancer Treatment

YANTAI, China, June 5, 2024 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, showcased its innovation in the field of global cancer treatment at the American Society of Clinical Oncology Annu...

2024-06-05 21:42 2436

Sunway Medical Centre retains Malaysia's top spot in Paediatrics, according to latest Newsweek rankings

The hospital is also ranked highly in the areas of Oncology, Neurology, Neurosurgery, Cardiology, and Cardiac Surgery. SUNWAY CITY, Malaysia, June 5, 2024 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, retained its to...

2024-06-05 20:00 2508

Crisis24 Combines Elite Concierge Medical Practice and Personal Protection Services to Form new Crisis24 Private Strategic Group division

Delivers "head of state" experience in personal protection and elite supplemental medical concierge services to world's most influential people, disruptive brands,and prominent organizations.  BOCA RATON, Fla., June 5, 2024 /PRNewswire/ -- Crisis24, a GardaWorld company, and a global leader in i...

2024-06-05 19:00 1433

Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations

CASTRES, France, June 5, 2024 /PRNewswire/ -- Pierre Fabre Laboratories today announced the filing of an investigational new drug ("IND") application to the U.S. Food and Drug Administration ("FDA") to initiate a first-in-human (FIH) Phase I/II clinical trial with PFL-002/VERT-002 for solid tumor...

2024-06-05 15:15 1933

Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series

XI'AN, China, June 5, 2024 /PRNewswire/ -- In honor of World Environment Day on 5 June,Tianlong , an innovative R&D company specializing in molecular diagnostic products, demonstrates its dedication to environmental sustainability and cleanliness through the introduction o...

2024-06-05 14:13 2449

ASG Pioneers Development of novel inhaled drugs and Accelerates R&D Progress

TAIPEI, June 5, 2024 /PRNewswire/ – Asia Scientific Global (ASG), a leader in the research and development of novel inhaled drugs, has set up a laboratory in Taiwan, and plans to establish a second facility in Singapore later this year. This new lab will focus on developing 505(b)2 new dosage form...

2024-06-05 12:30 1643

Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from 3P innovation

TORONTO, June 5, 2024 /PRNewswire/ -- Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a fully automated state-of-the-art high-speed aseptic powder filling line to expedite the ...

2024-06-05 10:00 1493

RestoringVision Awarded $4 Million Grant to Restore Sight to 2.5 Million People with Presbyopia in India and Nigeria

SAN FRANCISCO, June 4, 2024 /PRNewswire/ -- RestoringVision has been awarded a $4 million grant from Founders Pledge to address presbyopia at scale in India andNigeria. This investment will enable RestoringVision to implement three large-scale initiatives with its partners to provide reading glas...

2024-06-04 22:32 2101
1 ... 31323334353637 ... 396